1 Introduction
1.1 What Is This Report About?
1.2 Cardiovascular Surgery Devices Market Segmentation
1.3 Definitions of Markets Covered in the Report
2 Cardiovascular Surgery Devices Market, Australia
2.1 Cardiovascular Surgery Devices Market, Australia, Revenue ($m), 2024-2036
2.1.1 Beating Heart Surgery Systems Market, Australia, Revenue ($m), by Segment, 2024-2036
2.1.2 Perfusion Disposables Market, Australia, Revenue ($m), by Segment, 2024-2036
2.2 Cardiovascular Surgery Devices Market, Australia, Volume (Units), 2024-2036
2.2.1 Beating Heart Surgery Systems Market, Australia, Volume (Units), by Segment, 2024-2036
2.2.2 Perfusion Disposables Market, Australia, Volume (Units), by Segment, 2024-2036
2.3 Cardiovascular Surgery Devices Market, Australia, Average Price ($), 2024-2036
2.4 Cardiovascular Surgery Devices Market, Australia, Company Share by Revenue ($m), 2025
3 Cardiovascular Surgery Devices Market Pipeline Products
3.1 Cardiovascular Surgery Devices Market Pipeline Products
3.2 Cardiovascular Surgery Devices - Pipeline Products by Stage of Development
3.3 Cardiovascular Surgery Devices - Pipeline Products by Segment
3.4 Cardiovascular Surgery Devices - Pipeline Products by Territory
3.5 Cardiovascular Surgery Devices - Pipeline Products by Regulatory Path
3.6 Cardiovascular Surgery Devices - Pipeline Products by Estimated Approval Date
4 Overview of Key Companies in Australia, Cardiovascular Surgery Devices Market
4.1 Getinge AB
4.1.1 Company Overview
4.2 Nipro Corp
4.2.1 Company Overview
4.3 Terumo Corp
4.3.1 Company Overview
4.4 Abbott Laboratories
4.4.1 Company Overview
4.5 LivaNova Plc
4.5.1 Company Overview
4.6 MicroPort Scientific Corp
4.6.1 Company Overview
4.7 Medtronic Plc
4.7.1 Company Overview
4.8 Fresenius SE & Co KGaA
4.8.1 Company Overview
5 Recent Developments
5.1 Corporate Communications
5.1.1 Oct 15, 2025: Anteris Secures European Approval to Launch DurAVR® THV Global Pivotal Trial
5.2 Government and Public Interest
5.2.1 Oct 27, 2025: Anteris Technologies Reports One-Year Clinical Outcomes for DurAVR THV at TCT 2025
5.3 Other Significant Developments
5.3.1 Sep 11, 2025: ESC Congress 2025 Confirms Superior Predictive Value of Caristo FAI-Score™ Technology for Cardiac Death
5.4 Product News
5.4.1 Oct 27, 2025: Anteris Technologies Reports One-Year Clinical Outcomes for DurAVR THV at TCT 2025
5.4.2 Oct 15, 2025: Anteris Secures European Approval to Launch DurAVR® THV Global Pivotal Trial
5.4.3 Sep 11, 2025: ESC Congress 2025 Confirms Superior Predictive Value of Caristo FAI-Score™ Technology for Cardiac Death
6 Appendix
6.1 Research Methodology
6.1.1 Coverage
6.1.2 Secondary Research
6.1.3 Primary Research
6.1.4 Market Modeling and Forecasting
6.1.5 Company Share Analysis
6.1.6 Benchmarking
6.2 the analyst Consulting
6.3 Contact the Publisher
6.4 Disclaimer
List of Tables
Table 1: Cardiovascular Surgery Devices Market, Australia, Revenue ($m), USD Constant, 2024-2036
Table 2: Beating Heart Surgery Systems Market, Australia, Revenue ($m), USD Constant, 2024-2036
Table 3: Perfusion Disposables Market, Australia, Revenue ($m), USD Constant, 2024-2036
Table 4: Cardiovascular Surgery Devices Market, Australia, Volume (Units), 2024-2036
Table 5: Beating Heart Surgery Systems Market, Australia, Volume (Units), 2024-2036
Table 6: Perfusion Disposables Market, Australia, Volume (Units), 2024-2036
Table 7: Cardiovascular Surgery Devices Market, Australia, Average Price ($), 2024-2036
Table 8: Cardiovascular Surgery Devices Market, Australia, Company Share by Revenue ($m), USD Constant, 2025
Table 9: Cardiovascular Surgery Devices Market Pipeline Products
Table 10: Cardiovascular Surgery Devices - Pipeline Products by Stage of Development
Table 11: Cardiovascular Surgery Devices Companies - Pipeline Products by Stage of Development
Table 12: Cardiovascular Surgery Devices - Pipeline Products by Segment
Table 13: Cardiovascular Surgery Devices - Pipeline Products by Territory
Table 14: Cardiovascular Surgery Devices - Pipeline Products by Regulatory Path
Table 15: Cardiovascular Surgery Devices - Pipeline Products by Estimated Approval Date
Table 16: Total Number of Primary Research Participants, Cardiovascular devices Market, by Country
List of Figures
Figure 1: Cardiovascular Surgery Devices Market, Australia, Revenue ($m), USD Constant, 2024-2036
Figure 2: Beating Heart Surgery Systems Market, Australia, Revenue ($m), USD Constant, 2024-2036
Figure 3: Perfusion Disposables Market, Australia, Revenue ($m), USD Constant, 2024-2036
Figure 4: Cardiovascular Surgery Devices Market, Australia, Volume (Units), 2024-2036
Figure 5: Beating Heart Surgery Systems Market, Australia, Volume (Units), 2024-2036
Figure 6: Perfusion Disposables Market, Australia, Volume (Units), 2024-2036
Figure 7: Cardiovascular Surgery Devices Market, Australia, Company Share (%), 2025
Figure 8: Cardiovascular Surgery Devices - Pipeline Products by Stage of Development
Figure 9: Cardiovascular Surgery Devices - Pipeline Products by Segment
Figure 10: Cardiovascular Surgery Devices - Pipeline Products by Territory
Figure 11: Cardiovascular Surgery Devices - Pipeline Products by Regulatory Path
Figure 12: Cardiovascular Surgery Devices - Pipeline Products by Estimated Approval Date
